Yantai, China

Xiaoping Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Remegen, Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoping Zhang. Retrieved from https://idiyas.com/inventor/xiaoping-zhang-dhcff06e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiaoping Zhang

Introduction

Xiaoping Zhang is a notable inventor based in Yantai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. His work has the potential to impact various medical applications.

Latest Patents

Xiaoping Zhang holds a patent for an "ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF." This patent represents a significant advancement in targeted therapies, showcasing his expertise in antibody development. He has 1 patent to his name, reflecting his commitment to innovation in the medical field.

Career Highlights

Zhang is currently employed at Remegen Ltd., a company known for its focus on biopharmaceuticals. His role at Remegen allows him to further his research and development efforts in creating effective therapeutic solutions. His work is instrumental in advancing the company's mission to provide innovative treatments.

Collaborations

Xiaoping Zhang collaborates with talented individuals in his field, including Jianmin Fang and Yuanhao Li. These collaborations enhance the research environment and foster innovation within the team.

Conclusion

Xiaoping Zhang's contributions to biotechnology and his innovative patent demonstrate his dedication to advancing medical science. His work at Remegen Ltd. and collaborations with esteemed colleagues further highlight his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…